ArticleScience advances2025
A wearable tool for real-time dose monitoring during cancer radiation therapies.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence-integrated wearable biomedical devices for cancer management.Journal of the National Cancer Center · 2025Review
- From Structure to Performance: The Critical Role of DNTT Morphology in Organic TFTs.ACS applied materials & interfaces · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report on a wearable, human tissue-equivalent, real-time dosimeter designed to quantitatively monitor radiation absorbed by patients during cancer treatments. The fully organic device has been characterized under actual clinical conditions using a high-energy proton beam and an anthropomorphic phantom, with the aim to simulate a prostate cancer proton therapy treatment. We achieved a full control over the dosimeter operation, and we verified its linear response with the received dose. We demonstrate that, by a proper functionalization of the polysiloxane-based scintillator, it is possible to target the effective detection of different kinds of ionizing radiation. Specifically, besides protons, we develop a device able to detect thermal neutrons, targeting its use during Boron Neutron Capture Therapy. This work demonstrates how organic indirect detectors can be considered a universal radiation detecting platform able to monitor in real time and in situ the dose absorbed by patients during cancer treatments under different kinds of radiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.